Prof. dr. A.C.G. Egberts

Farmaceutische wetenschappen

BIG nr. 39027898417

Aandachtsgebieden uitklapper, klik om te openen

Drug Innovation

Neuroscience & Cognition Utrecht

Epidemiology

Wetenschappelijk onderzoek en publicaties uitklapper, klik om te openen

• Giezen TJ, Mantel-Teeuwisse AK, Straus SM, Schellekens H, Leufkens HG, Egberts AC. Safety-related regulatory actions for biologicals approved in the United States and the European Union. JAMA. 2008 Oct22;300(16):1887-96.
• Leendertse AJ, Egberts AC, Stoker LJ, van den Bemt PM; HARM StudyGroup. Frequency of and risk factors for preventable medication-related hospital admissions in the Netherlands. Arch Intern Med. 2008 Sep22;168(17):1890-6.
• Mulder H, Franke B, van der-Beek van der AA, Arends J, Wilmink FW, Scheffer H, Egberts AC. The association between HTR2C gene polymorphisms and the metabolic syndrome in patients with schizophrenia. J Clin Psychopharmacol. 2007 Aug;27(4):338-43.
• Kuijpers MA, van Marum RJ, Egberts AC, Jansen PA; OLDY (OLd peopleDrugs & dYsregulations) Study Group. Relationship between polypharmacy and under prescribing. Br J Clin Pharmacol. 2008Jan;65(1):130-3.
• ten Berg MJ, Huisman A, van den Bemt PM, Schobben AF, Egberts AC, vanSolinge WW. Linking laboratory and medication data: new opportunities for pharmacoepidemiological research. Clin Chem Lab Med.2007;45(1):13-9.